ZTS - Zoetis Inc.

Zoetis Inc. is a leading global company in the animal health sector, dedicated to the discovery, development, manufacture, and commercialization of medications, vaccines, diagnostic products, and services aimed at improving animal health. The company operates across eight core species, which include companion animals like dogs and cats, and livestock such as cattle and poultry, dedicating efforts to offer a wide array of products that encompass various health needs, from parasiticides to vaccines and diagnostics. Over its 70 years of experience, Zoetis has built a diverse portfolio with approximately 300 product lines, emphasizing continuous innovation in both companion animal and livestock care.

The company's operational structure is categorized into two main segments: the United States, which constitutes over half of their revenue, and International markets, which provide considerable growth potential. With growing demand in emerging markets due to population growth and rising standards of living, Zoetis focuses on enhancing its research and development capabilities and strategic acquisitions to strengthen its position in the animal health industry. As the company fosters customer relationships through its extensive sales and veterinary operations teams, it is adept at addressing regional specificities and customer needs, allowing for tailored solutions that reinforce their commitment to animal health worldwide.